Urinary Retention and Voiding Dysfunction

Neuro-Urology ◽  
2018 ◽  
pp. 207-231
Author(s):  
Dominique Malacarne Pape ◽  
Victor W. Nitti
Keyword(s):  
Urinary Retention ◽  
Voiding Dysfunction

Molecular mechanisms of voiding dysfunction in a novel mouse model of acute urinary retention

2021 ◽  
Vol 35 (4) ◽  
Author(s):  
Xiang Xie ◽  
Huan Chen ◽  
Lanlan Zhang ◽  
Daniel Chan ◽  
Warren G. Hill ◽  
...  
Keyword(s):  
Mouse Model ◽  
Urinary Retention ◽  
Acute Urinary Retention ◽  
Molecular Mechanisms ◽  
Voiding Dysfunction

scholarly journals Sacral Neuromodulation for Refractory Urge Incontinence Is Less Effective Following Spinal Surgery

2011 ◽  
Vol 11 ◽  
pp. 142-146 ◽  
Author(s):  
Angela M. Arlen ◽  
Charles R. Powell ◽  
Karl J. Kreder
Keyword(s):  
Success Rate ◽  
Urinary Retention ◽  
Spinal Surgery ◽  
Urge Incontinence ◽  
Neurological Disease ◽  
Voiding Dysfunction ◽  
Sacral Neuromodulation ◽  
Clinical Success ◽  
History Of

Patients with neurogenic disorders and voiding dysfunction have been reported to respond poorly to sacral neuromodulation. We report on our experience in treating voiding symptoms with sacral neuromodulation after spinal surgery. The medical charts of patients evaluated for sacral neuromodulation from 2000–2008 were retrospectively reviewed. Indications, need for explantation, and clinical success (>50% symptom improvement) were recorded. The cohort of patients who had undergone prior spinal surgery was compared to patients with no history of spinal surgery or neurological disease. Thirty-two patients with a history of spinal surgery and 136 with no history of neurologic disease underwent sacral neuromodulation testing. Twenty men and women (62.5%) from the spinal surgery group ultimately underwent permanent implantation. Seventeen of the 32 patients were diagnosed with urge incontinence, of whom 52.9% reported a successful outcome at a mean of 2.3 years of follow-up, compared to an 80.3% success rate in patients with no history of spinal surgery (p= 0.018). Sixteen of 32 carried a diagnosis of urgency/frequency with 62.5% success at last follow-up, compared 73.9% (p= 0.35) of those without a history of spinal surgery or neurological disease. Thirteen of 32 patients diagnosed with urinary retention experienced a 61.5% long-term success rate, compared with 63.6% for those without spinal surgery and urinary retention. Six of 20 (30.0%) in the spinal surgery group were explanted at a mean time of 2.9 years, compared with 27 of 102 (26.5%) of the non-neurologic patients. Clinical success can be achieved using sacral neuromodulation in patients with voiding dysfunction and a history of spinal surgery; however, those with urge incontinence are less likely to report significant improvement.

scholarly journals Effect of sacral neuromodulation on female sexual function and quality of life: Are they correlated?

2014 ◽  
Vol 8 (11-12) ◽  
pp. 762 ◽  
Author(s):  
Mai Ahmed Banakhar ◽  
Yahya Gazwani ◽  
Mohamed ElKelini ◽  
Tariq Al-shaiji ◽  
Magdy Hassouna
Keyword(s):  
Quality Of Life ◽  
Overactive Bladder ◽  
Sexual Function ◽  
Urinary Retention ◽  
Voiding Dysfunction ◽  
Sacral Neuromodulation ◽  
Response To Therapy ◽  
Female Sexual Function ◽  
Female Patients

Introduction: Sacral neuromodulation (SNM) has become an established therapy for voiding dysfunction. Additional benefits, such as improved bowel functions and bladder pain, have been reported. Improvement in female sexual function after SNM treatment has been suggested; however, reports examining the effects of SNM on female sexual functions are scarce. We evaluate the effects of SNM on female sexual function and its impact on quality of life and analyze any correlation.Methods: Data were collected from January 2010 to May 2012 for all female patients who underwent SNM InterStim (Medtronic, Minneapolis, MN) therapy at a single centre in Canada. They were treated for voiding dysfunction, including refractory overactive bladder, frequency-urgency syndrome and non-obstructive urinary retention. Patients were screened by percutaneous nerve evaluation (PNE) to assess their response to therapy using a 4-day voiding diary. Patients who experienced 50% or more improvement in their voiding parameters were permanently implanted. All patients completed the Female Sexual Function Index (FSFI), Short-Form Health Survey (SF-36), and incontinence questionnaires (Urinary Distress Inventory [UDI]-6) preoperatively and 4 months postoperatively.Results: A total of 33 female patients had SNM therapy; 10 were excluded from the study because they were not sexually active. The indications were: refractory overactive bladder in 19, frequency urgency syndrome in 2, and non-obstructive urinary retention in another 2 patients. SNM therapy significantly improved the total FSFI score (p = 0.011); the components of desire and orgasm showed significant improvement (p = 0.014 and p = 0.035, respectively). Age, body mass index, diagnosis, and urinary symptoms did not show significant correlation with FSFI score improvement. Quality of life showed significant improvement after SNM treatment in 5 categories. There was no correlation between improvement in quality of life and FSFI.Conclusion: SNM may improve female sexual function and quality of life, yet there is no correlation between the improvement in FSFI and quality of life. 

Sign in / Sign up

Export Citation Format

Share Document